Kuros Biosciences AG (LON: 0RHR)
London
· Delayed Price · Currency is GBP · Price in CHF 21.15
-0.85 (-3.86%)
Jan 23, 2025, 12:20 PM BST
Kuros Biosciences AG Revenue
Kuros Biosciences AG had revenue of 31.84M CHF in the half year ending June 30, 2024, with 205.43% growth. This brings the company's revenue in the last twelve months to 52.54M, up 157.23% year-over-year. In the year 2023, Kuros Biosciences AG had annual revenue of 33.56M with 86.61% growth.
Revenue (ttm)
52.54M CHF
Revenue Growth
+157.23%
P/S Ratio
n/a
Revenue / Employee
656.78K CHF
Employees
80
Market Cap
729.81M GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |